Condition: Pancreatic Cancer · Unresectable Pancreatic Cancer · Metastatic Pancreatic Cancer · Sponsor: Alpha Tau Medical LTD.
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer
This description comes directly from the study's public registry record.
Liron Dimnik · +972-2-3737-7000 · LironD@alphatau.com
Aviya Hoida · +972-2-3737-210 · aviyah@alphatau.com
Always discuss trial participation with your own doctor first.
| Wolfson Medical Center | Holon, Israel | Not Yet Recruiting |
| Hadassah Ein Kerem | Jerusalem, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05657743